[DPHARMA] QoQ TTM Result on 31-Mar-2019 [#1]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
21-May-2019
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2019
Quarter
31-Mar-2019 [#1]
Profit Trend
QoQ- 7.71%
YoY- 17.73%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
TTM Result
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
Revenue 576,462 554,341 537,324 515,849 498,722 495,341 484,882 12.18%
PBT 70,809 74,528 70,598 65,197 59,666 54,833 53,202 20.93%
Tax -15,536 -16,919 -15,562 -13,738 -12,025 -9,793 -9,321 40.44%
NP 55,273 57,609 55,036 51,459 47,641 45,040 43,881 16.58%
-
NP to SH 55,273 57,609 55,036 51,459 47,776 45,277 44,396 15.68%
-
Tax Rate 21.94% 22.70% 22.04% 21.07% 20.15% 17.86% 17.52% -
Total Cost 521,189 496,732 482,288 464,390 451,081 450,301 441,001 11.74%
-
Net Worth 525,364 505,919 503,029 496,410 483,173 501,487 209,983 83.98%
Dividend
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
Div 40,733 33,094 33,094 30,674 30,674 20,937 20,937 55.65%
Div Payout % 73.69% 57.45% 60.13% 59.61% 64.21% 46.24% 47.16% -
Equity
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
Net Worth 525,364 505,919 503,029 496,410 483,173 501,487 209,983 83.98%
NOSH 684,383 680,106 661,881 661,881 661,881 661,881 650,902 3.39%
Ratio Analysis
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
NP Margin 9.59% 10.39% 10.24% 9.98% 9.55% 9.09% 9.05% -
ROE 10.52% 11.39% 10.94% 10.37% 9.89% 9.03% 21.14% -
Per Share
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
RPS 84.49 82.18 81.18 77.94 75.35 75.07 173.19 -37.94%
EPS 8.10 8.54 8.32 7.77 7.22 6.86 15.86 -36.02%
DPS 5.97 5.00 5.00 4.63 4.63 3.17 7.50 -14.07%
NAPS 0.77 0.75 0.76 0.75 0.73 0.76 0.75 1.76%
Adjusted Per Share Value based on latest NOSH - 661,881
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
RPS 59.88 57.58 55.82 53.59 51.81 51.46 50.37 12.18%
EPS 5.74 5.98 5.72 5.35 4.96 4.70 4.61 15.69%
DPS 4.23 3.44 3.44 3.19 3.19 2.17 2.17 55.85%
NAPS 0.5457 0.5255 0.5225 0.5157 0.5019 0.5209 0.2181 83.99%
Price Multiplier on Financial Quarter End Date
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
Date 31/12/19 30/09/19 28/06/19 29/03/19 31/12/18 28/09/18 29/06/18 -
Price 1.42 1.40 1.37 1.28 0.95 1.23 1.30 -
P/RPS 1.68 1.70 1.69 1.64 1.26 1.64 0.75 70.94%
P/EPS 17.53 16.39 16.48 16.46 13.16 17.93 8.20 65.72%
EY 5.70 6.10 6.07 6.07 7.60 5.58 12.20 -39.70%
DY 4.20 3.57 3.65 3.62 4.88 2.58 5.77 -19.03%
P/NAPS 1.84 1.87 1.80 1.71 1.30 1.62 1.73 4.18%
Price Multiplier on Announcement Date
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
Date 13/02/20 29/11/19 30/08/19 21/05/19 18/02/19 28/11/18 26/11/18 -
Price 1.64 1.39 1.41 1.36 1.03 1.07 1.08 -
P/RPS 1.94 1.69 1.74 1.75 1.37 1.43 0.62 113.48%
P/EPS 20.24 16.28 16.96 17.49 14.27 15.59 6.81 106.30%
EY 4.94 6.14 5.90 5.72 7.01 6.41 14.68 -51.52%
DY 3.64 3.60 3.55 3.41 4.50 2.97 6.94 -34.88%
P/NAPS 2.13 1.85 1.86 1.81 1.41 1.41 1.44 29.72%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment